跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-VENLAFAXINE XR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
M-VENLAFAXINE XR
Authorized
STANDARD
M-VENLAFAXINE XR
mantra pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8def6a6938de78a2
Company
mantra pharma inc
Type
Standard
Approval Details
Approval Id
8def6a6938de78a2
Drug Approval Canada Name
M-VENLAFAXINE XR
Product Name
M-VENLAFAXINE XR
Status
Marketed
Status Date
2018-03-07
Original Market Date
2018-03-07
Din
02471280
Drug Class
Human
Dosage Form
Capsule (Extended Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.16
Atc Original
N06AX16 VENLAFAXINE
Atc Name
n 06 ax 16
Aig Number
0131294002
Company Name
mantra pharma inc
Company Address
1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3
Active Ingredients
VENLAFAXINE (VENLAFAXINE HYDROCHLORIDE)
37.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8def6a6938de78a2
Type
Standard
Back to Health Canada Approvals